| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |